RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,374,000 | +40.3% | 486,872 | +37.1% | 0.02% | +66.7% |
| Q4 2019 | $16,664,000 | +1488.6% | 355,090 | +700.0% | 0.01% | +1100.0% |
| Q3 2019 | $1,049,000 | -3.2% | 44,386 | +23.0% | 0.00% | 0.0% |
| Q2 2019 | $1,084,000 | -11.6% | 36,093 | -34.0% | 0.00% | 0.0% |
| Q1 2019 | $1,226,000 | -21.7% | 54,727 | -81.4% | 0.00% | 0.0% |
| Q1 2018 | $1,565,000 | +957.4% | 294,681 | +2803.0% | 0.00% | – |
| Q3 2017 | $148,000 | – | 10,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|